BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7309030)

  • 21. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
    Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow involvement in cutaneous mastocytosis.
    Fearfield LA; Francis N; Henry K; Costello C; Bunker CB
    Br J Dermatol; 2001 Mar; 144(3):561-6. PubMed ID: 11260015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of systemic mastocytosis using a semiquantitative method of assessing the mast cell population].
    Tomilov AF; Podivilova TN
    Ter Arkh; 1990; 62(4):108-11. PubMed ID: 2392747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone evaluation in ten adults with cutaneous mastocytosis].
    Armingaud P; Zerkak D; Lespessailles E; Petavy-Catala C; Kerdraon R; Benhamou CL; Estève E
    Ann Dermatol Venereol; 2002 Feb; 129(2):170-2. PubMed ID: 11937953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of mastocytosis.
    Tharp MD
    Am J Med Sci; 1985 Mar; 289(3):119-32. PubMed ID: 2579553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
    Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
    Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature.
    Rafii M; Firooznia H; Golimbu C; Balthazar E
    Clin Orthop Relat Res; 1983 Nov; (180):260-7. PubMed ID: 6354546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic mastocytosis in a goat.
    Khan KN; Sagartz JE; Koenig G; Tanaka K
    Vet Pathol; 1995 Nov; 32(6):719-21. PubMed ID: 8592810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
    Stamm AC; Burbelko M; Rominger M
    Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
    [No Abstract]   [Full Text] [Related]  

  • 34. [Systemic mastocytosis: a case with diffuse bone involvement].
    Biarese V; Raviolo P; Cesarani F; Lobetti L
    Minerva Med; 1996; 87(1-2):33-9. PubMed ID: 8610023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R; Butterfield J
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic mastocytosis presenting with severe spinal osteopenia and multiple compression fractures.
    Floman Y; Amir G
    J Spinal Disord; 1991 Sep; 4(3):369-73. PubMed ID: 1802168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous and systemic mastocytosis in adults. A clinical, histopathological and immunological evaluation in relation to histamine metabolism.
    Olafsson JH
    Acta Derm Venereol Suppl (Stockh); 1985; 115():1-43. PubMed ID: 3901645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary thrombocythaemia associated with systemic mastocytosis: a report of five cases.
    Le Tourneau A; Gaulard P; D'Agay MF; Vainchencker W; Cadiou M; Devidas A; Haioun C; Clauvel JP; Audouin J; Diebold J
    Br J Haematol; 1991 Sep; 79(1):84-9. PubMed ID: 1911390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.
    Escribano L; Díaz Agustín Beatriz ; Bravo P; Navalón R; Almeida J; Orfao A
    Leuk Lymphoma; 1999 Oct; 35(3-4):227-35. PubMed ID: 10706445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.